Department of Urology, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Department of Urology, Tokyo Women's Medical University Medical Center East, 2-1-10 Nishiogu, Arakawa-ku, Tokyo, 116-8567, Japan.
Int J Clin Oncol. 2020 Jun;25(6):1155-1162. doi: 10.1007/s10147-020-01633-w. Epub 2020 Feb 17.
When local recurrence of renal cell carcinoma (RCC) occurs after nephron-sparing surgery (NSS) on the ipsilateral side, some surgeons hesitate to perform reoperative surgery because of possible difficulties. We aimed to evaluate the clinical outcomes of repeat partial nephrectomy (RePN) compared with those of initial partial nephrectomy (iPN) for RCC of a solitary kidney.
Until September 2017, 1671 patients with renal tumors underwent NSS. Of these, 79 patients who underwent NSS for sporadic RCC of a solitary kidney were included. Parameters were compared using the Mann-Whitney U, Pearson Chi-square, and Fisher exact tests.
Eleven patients underwent RePN and 68 underwent iPN. The RePN group had a relatively smaller tumor size (p = 0.0432), longer operative time (p = 0.0432), and higher estimated blood loss (p = 0.0002) than the iPN group. No significant differences in the other clinical factors were found between the groups. The rates of perioperative complications greater than Clavien-Dindo grade II were 18.2% and 17.6% in the RePN group and iPN group, respectively. The mean decreasing rate of estimated glomerular filtration rate was not different between the groups at 3 and 6 months postoperatively. No significant differences were found in hemodialysis-free survival (p = 0.7392) and intrarenal recurrence-free survival (p = 0.4924) between the groups.
The clinical outcomes of RePN were not significantly different compared with those of iPN for patients with sporadic RCC of a solitary kidney. RePN is technically feasible with acceptable complication and local recurrence rates with better postoperative kidney function.
当肾细胞癌 (RCC) 在同侧行保留肾单位手术 (NSS) 后发生局部复发时,由于可能存在困难,一些外科医生对再次手术犹豫不决。我们旨在评估复发性部分肾切除术 (RePN) 与单侧孤立肾 RCC 的初始部分肾切除术 (iPN) 的临床结果。
截至 2017 年 9 月,1671 例患者接受了肾肿瘤 NSS。其中,79 例患者因单侧孤立肾散发性 RCC 接受了 NSS。使用 Mann-Whitney U、Pearson Chi-square 和 Fisher 确切检验比较参数。
11 例患者接受 RePN,68 例患者接受 iPN。RePN 组肿瘤直径较小 (p=0.0432)、手术时间较长 (p=0.0432) 和估计出血量较高 (p=0.0002)。两组之间其他临床因素无显著差异。RePN 组和 iPN 组的围手术期并发症发生率大于 Clavien-Dindo Ⅱ级分别为 18.2%和 17.6%。两组术后 3 个月和 6 个月估算肾小球滤过率的平均下降率无差异。两组无血液透析无复发生存率 (p=0.7392) 和肾内无复发生存率 (p=0.4924) 无显著差异。
与单侧孤立肾散发性 RCC 患者的 iPN 相比,RePN 的临床结果并无显著差异。RePN 在技术上是可行的,具有可接受的并发症和局部复发率,术后肾功能更好。